Key result
Sinus rhythm maintenance 30 days after electrical cardioversion was associated with significant reductions in BMP10 (-10.4%) and NT-proBNP (-62.0%) compared to patients with atrial fibrillation recurrence.
Why the study?
Biomarkers may help to improve knowledge about the complex pathophysiology of AF, but changes related to rhythm status after electrical cardioversion were unclear.
Are changes in biomarker levels (such as BMP10 and NT-proBNP) associated with rhythm status at 30 days in patients with persistent atrial fibrillation undergoing electrical cardioversion?
Cohort (n=100)
Blinded outcome assessment
No
Are changes in biomarker levels (such as BMP10 and NT-proBNP) associated with rhythm status at 30 days in patients with persistent atrial fibrillation undergoing electrical cardioversion?
Mean Difference: -13.5 (95% CI -19.3–-7.6)
Absolute Event Rate: -10.4% vs 3.1%
p-value: p=<0.001
Changes in BMP10 and NT-proBNP levels are strongly associated with rhythm status 30 days after electrical cardioversion for persistent atrial fibrillation, suggesting these biomarkers reflect actual heart rhythm.
Reductions in BMP10 and NT-proBNP track sinus rhythm after cardioversion; leaves open their utility for monitoring AF recurrence pending prospective validation.
Background Biomarkers may help to improve our knowledge about the complex pathophysiology of atrial fibrillation (AF), the most common sustained cardiac arrhythmia. We aimed to identify significant changes in biomarkers and clinical measures in patients with and without AF recurrence after electrical cardioversion. Methods Patients with persistent AF undergoing elective electrical cardioversion were enrolled. We measured 21 conventional and new biomarkers before and 30 days after electrical cardioversion and assessed the associations of changes in biomarker levels with rhythm status at follow-up using multivariable logistic regression models. Results Of the 100 patients included (mean [SD] age 66 (10) years, 25% women), 28 (28%) had an AF recurrence. Of the 21 biomarkers assessed, 4 reached the predefined between group significance of p<0.01. The most significant ones were bone morphogenetic protein 10 (BMP10), N-terminal pro-B-type natriuretic peptide (NT-proBNP) and total bilirubin. Their respective changes were -10.4%, -62.0% and -25.6% in patients with sinus rhythm, and 3.1%, 1.1% and -9.4% in patients with recurrent AF, for a between group difference of -13.5% (95% confidence interval [CI], -19.3% to -7.6%; P<0.001), -63.1% (95% CI, -76.6% to -49.6%; P<0.001) and -16.3 (95% CI, -27.9% to -4.7%; P=0.007). In age and sex adjusted models, reductions of BMP10 and NT-proBNP were significantly associated with rhythm status at follow-up (β coefficient per 1-SD decrease, -2.03; 95% CI, -3.06 to -1.00; P<0.001 and -3.98; 95% CI, -5.75 to -2.22; P<0.001, respectively). After additional adjustment for demographic characteristics, risk factors for AF, and changes in clinical measures, the β coefficients per 1-SD were -3.85 (95% CI, -6.34 to -1.35; P=0.003) for BMP10 and -5.84 (95% CI, -10.22 to -1.47; P=0.009) for NT-proBNP. Conclusions Changes in BMP10 und NT-proBNP levels were strongly associated with rhythm status after electrical cardioversion, suggesting that these markers may be dependent on the actual heart rhythm.
No takes yet. Share an insight, caveat, or question.
Meyre et al. (2021) conducted a cohort in Persistent Atrial Fibrillation (n=100). Sinus rhythm maintenance vs. Atrial fibrillation recurrence was evaluated on Percent change in BMP10 levels at 30 days (MD -13.5%, 95% CI -19.3 to -7.6, p=<0.001). Sinus rhythm maintenance 30 days after electrical cardioversion was associated with significant reductions in BMP10 (-10.4%) and NT-proBNP (-62.0%) compared to patients with atrial fibrillation recurrence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: